Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation

Pulmonary fibrosis (PF) is one of the sequelae of Corona Virus Disease 2019 (COVID-19), and currently, lung transplantation is the only viable treatment option. Hence, other effective treatments are urgently required. We investigated the therapeutic effects of an approved botanical drug, cepharanthi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guangrui, Li, Jian, Liu, Huimeng, Zhou, Huiyu, Liu, Mingqiu, Liang, Di, Meng, Zhiyun, Gan, Hui, Wu, Zhuona, Zhu, Xiaoxia, Han, Peng, Liu, Taoyun, Gu, Ruolan, Liu, Shuchen, Dou, Guifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864377/
https://www.ncbi.nlm.nih.gov/pubmed/36677811
http://dx.doi.org/10.3390/molecules28020753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864377/
https://www.ncbi.nlm.nih.gov/pubmed/36677811
http://dx.doi.org/10.3390/molecules28020753

Ejemplares similares